Literature DB >> 2542449

Rapid preparation of a distinct lysosomal population from myelinating mouse brain using Percoll gradients.

L Caimi1, S Marchesini, M F Aleo, R Bresciani, E Monti, A Casella, M L Giudici, A Preti.   

Abstract

To study the vesicular lysosome-associated transport and the metabolism of some brain macromolecules (in particular, sialoglycoconjugates), we developed a rapid procedure to obtain a distinct lysosomal population starting from myelinating mouse brain. This procedure is based on an initial differential centrifugation step producing a 1,000-17,500-g fraction (P2), followed by isopycnic centrifugation of fraction P2 on a self-generated colloidal silica gel (Percoll) gradient. The heaviest subfraction thus obtained is very rich in acid hydrolase activities like beta-galactosidase, arylsulfatase A, and acid phosphatase. The enrichment of these enzymes is approximately 100-fold as compared with the starting homogenate, whereas the markers of other subcellular organelles, such as mitochondria, plasma membranes, or the Golgi apparatus, are virtually absent. The lysosomal preparation contains approximately 12-14% of the total acid hydrolase activities, with a protein yield of approximately 0.12%. Electron microscopy shows that the lysosomal fraction is composed of an approximately 90% pure population of lysosomes. Therefore, the procedure described here is suitable for obtaining a highly purified lysosome preparation from myelinating mouse brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542449     DOI: 10.1111/j.1471-4159.1989.tb07250.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Isolation of highly purified rat cerebral lysosomes using percoll gradients with a variety of calcium concentrations.

Authors:  T Taguchi; K Akimaru; M Yamasakt; S Ryu; E Miyamoto; Y Takano; A Sato
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

2.  A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease.

Authors:  Heike Wolf; Markus Damme; Stijn Stroobants; Rudi D'Hooge; Hans Christian Beck; Irm Hermans-Borgmeyer; Renate Lüllmann-Rauch; Thomas Dierks; Torben Lübke
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

3.  Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.

Authors:  Rona Wilson; Clive Bate; Ronald Boshuizen; Alun Williams; James Brewer
Journal:  BMC Neurosci       Date:  2007-11-22       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.